한국 폐경여성에서 식물성 에스트로겐 이소플라본의 섭취 현황 = Survey on the Consumption of the Phytoestrogen Isoflavone in Postmenopausal Korean Women

다국어 초록 (Multilingual Abstract)

Objectives: Isoflavone is a plant-derived compound, abundant in soy food, and its character is mixed estrogenic and antiestrogenic action, so it is highlighted as an alternative to hormone replacement therapy (HRT) in postmenopausal women. The purpose of this study is to establish a foundation for isoflavone study in the future, by estimating isoflavone intake in postmenopausal women and by recommending proper isoflavone intake. Methods: Isoflavone intake was estimated in a total of 189 Korean postmenopausal women over 50 years old, by using a food frequency questionnaire (FFQ). Data were statistically analyzed by t-test, and one-way ANOVA with Turkey`s test. Results: The daily average isoflavone intake level was 21.94 ± 19.96 mg. There is no significant difference in isoflavone intake according to age. About 60 percentile of postmenopausal women intake isoflavone under 20 mg a day, and 2 percentile of postmenopausal women intake about 80 mg isoflavone. Conclusion: There was no definite precise amount of isoflavone for reliving postmenopausal symptom and health. But through this study, most postmenopausal women did not intake enough isoflavone, so they have to intake more isoflavone. (J Korean Soc Menopause 2012;18:163-173)

참고문헌 (Reference)

1 Polo-Kantola P, "When does estrogen replacement therapy improve sleep quality?" 178 : 1002-1009, 1998

2 Lee BS, "The effect of isoflavone on serum lipid profiles and bone markers in postmenopausal women" 8 : 59-67, 2002

3 Won HJ, "The effect of isoflavone on postmenopausal symptoms and hormonal changes in postmenopausal women" 7 : 54-63, 2001

4 Albertazzi P, "The effect of dietary soy supplementation on hot flushes" 91 : 6-11, 1998

5 Rossouw JE, "Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial" 288 : 321-333, 2002

6 Husband A, "Red clover isoflavone supplements: safety and pharmacokinetics" 7 (7): 4-7, 2001

7 Ewies AA, "Phytoestrogens in the management of the menopause: up-to-date" 57 : 306-313, 2002

8 Horn-Ross PL, "Phytoestrogen consumption and breast cancer risk in a multiethnic population: the Bay Area Breast Cancer Study" 154 : 434-441, 2001

9 Hersh AL, "National use of postmenopausal hormone therapy: annual trends and response to recent evidence" 291 : 47-53, 2004

10 Choi YB, "Isoflavone content in Korean fermented and unfermented soybean foods" 30 : 745-750, 1998

11 Boker LK, "Intake of dietary phytoestrogens by Dutch women" 132 : 1319-1328, 2002

12 Soules MR, "Executive summary: Stages of Reproductive Aging Workshop (STRAW) Park City, Utah, July, 2001" 8 : 402-407, 2001

13 Notelovitz M, "Estrogen replacement therapy: indications, contraindications, and agent selection" 161 : 1832-1841, 1989

14 Manson JE, "Estrogen plus progestin and the risk of coronary heart disease" 349 : 523-534, 2003

15 Lee SK, "Estimated isoflavone intake from soy products in Korean middle-aged women" 29 : 948-956, 2000

16 Kim J, "Estimated dietary isoflavone intake of Korean population based on National Nutrition Survey" 21 : 947-953, 2001

17 이민준, "Estimated dietary isoflavone intake among Korean adults" 한국영양학회 1 (1): 206-211, 2007

18 Messina M, "Estimated Asian adult soy protein and isoflavone intakes" 55 : 1-12, 2006

19 Palacios S, "Endometrial safety assessment of a specific and standardized soy extract according to international guidelines" 14 : 1006-1011, 2007

20 Unfer V, "Endometrial effects of long-term treatment with phytoestrogens: a randomized, double-blind, placebocontrolled study" 82 : 145-148, 2004

21 Penotti M, "Effect of soy-derived isoflavones on hot flushes, endometrial thickness, and the pulsatility index of the uterine and cerebral arteries" 79 : 1112-1117, 2003

22 Levis S, "Design and baseline characteristics of the soy phytoestrogens as replacement estrogen (SPARE) study--a clinical trial of the effects of soy isoflavones in menopausal women" 31 : 293-302, 2010

23 Scambia G, "Clinical effects of a standardized soy extract in postmenopausal women: a pilot study" 7 : 105-111, 2000

24 Kim WW, "An immunohistochemical study on alkaline phosphatase activity in osteoblasts cultured with isoflavone" 8 : 19-26, 2002

25 Messina M, "Addressing the soy and breast cancer relationship: review, commentary, and workshop proceedings" 98 : 1275-1284, 2006

26 Setchell KDR, "Absorption and metabolism of isoflavones" 6 : 1-3, 2008

27 Sung CJ, "A study on dietary isoflavone intake from soy food and urinary isoflavone excretion and, menopausal symptoms in Korean women in rural areas" 5 : 120-129, 2000

28 Nikander E, "A randomized placebocontrolled crossover trial with phytoestrogens in treatment of menopause in breast cancer patients" 101 : 1213-1220, 2003

29 최미경, "20세 이상 남녀의 일상 식이중 이소플라본 섭취와 혈압, 혈중 지질과의 관련성" 대한지역사회영양학회 10 (10): 493-500, 2005